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Open access under tSesquiterpene lactones (SLs) are natural products with a variety of biological activities. Previously, we
demonstrated the cytotoxic effects of three new a-santonin derivatives on different tumor cell lines with
low toxic effects upon peripheral human leukocytes. Here, we evaluated the mechanism of action trig-
gered by these derivatives. HL-60 cell cycle determined after 24 h treatment revealed a signiﬁcant inhi-
bition on cell-cycle progression and leading to an increasing of cells in G2/M [7.6% and 9.0% for compound
3% and 9.0% and 8.6% for compound 4 (1 and 2 lM, respectively)]. However, after 48 h exposure, all com-
pounds caused G2/M reduction and a signiﬁcant DNA fragmentation. Compounds 2, 3 and 4 were able to
induce apoptosis on leukemia cells, which was corroborated by phosphatidyserine externalization and
activation of caspases-3 and -7 after 24 h exposure. None of the derivatives analyzed caused depolariza-
tion of mitochondrial membrane within 24 h of incubation, suggesting the involvement of the extrinsic
apoptotic pathway in the death process. The antiproliferative action of these compounds is related to the
DNA synthesis inhibition and cell cycle arrest, which probably lead to apoptosis activation. Therefore,
these santonin derivatives are promising lead candidates for development of new cytotoxic agents.
 2013 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
Cancer is a disease caused by disorderly growth of cells that of-
ten invade tissues and organs. Considerable insight has been
gained into the mechanisms by which some chemicals affect cellu-
lar growth and this knowledge has been used to design new more
selective chemotherapeutic drugs towards cancer cells than to nor-
mal cells and reduce side effects (Benz and Yau, 2008).
The development of antineoplasic agents is important to dimin-
ish the mortality caused by cancer. Since cell homeostasis depends
on the balance between proliferation and cell death, effective com-
pounds that increase apoptosis without concomitant increases cel-
lular proliferation appear to be a relevant strategy to suppressr Helvídio Nunes de Barros
Brazil. Tel.: +55 89 34221008;
fpi.edu.br (P.M.P. Ferreira).
he Elsevier OA license.tumor growth (Kaufmann and Earnshaw, 2000; Ferreira et al.,
2010).
Despite the interest in molecular modeling and combinatorial
chemistry, the search for novel anticancer drugs from natural
and non-natural sources has continued through the collaboration
of scientists worldwide in looking for new bioactive compounds
(Kiran et al., 2008; Cragg et al., 2009; Ferreira et al., 2011). Among
the large sources of potential compounds natural products offer
opportunities to evaluate not only totally new chemical classes
of anticancer agents, but also novel and potentially relevant mech-
anisms of action. The majority of anticancer drugs are natural
products or their derivatives and more than 200 drugs derived
from natural products are in preclinical or clinical development
and evaluation (Ghantous et al., 2010; Newman and Cragg, 2012).
Sesquiterpene lactones (SLs) are a class of naturally occurring
plant terpenoids of the Asteraceae family, known for their various
biological activities such as anti-inﬂammatory, phytotoxic, antimi-
crobial, antiprotozoal, and cytotoxic against different tumor cell
lines (Hehner et al., 1998; Mazor et al., 2000; Schmidt et al.,
J.R.O. Ferreira et al. / Toxicology in Vitro 27 (2013) 1458–1466 14592002; Zhang et al., 2005). a-Santonin, a sesquiterpene lactone iso-
lated from Artemisia santonica presents antipyretic, anti-parasitic
and anti-inﬂammatory properties (Ivasenko et al., 2006). Some
a-santonin derivatives also act as inhibitors of phospholipase A2
enzymes from Bothrops jararacussu (De Alvarenga et al., 2011).
Additionally, we have reported the activity of synthetic a-santonin
derivatives against several human cancer cell lines (HL-60, leuke-
mia; SF-295; glioblastoma; HCT-8, colon; MDA/MB-435, mela-
noma) with low antiproliferative effects upon normal human
leukocytes (Arantes et al., 2009, Arantes et al., 2010). Therefore,
these results indicate that SLs and related compounds may repre-
sent a promising class of biological agents. In this work, we de-
scribed, for the ﬁrst time, the mechanism of induction of cell
death on human promyelocytic leukemia HL-60 cell line triggered
by three a-santonin derivatives.2. Methods
2.1. Chemicals
Fetal calf serum was purchased from Cultilab (Campinas, SP),
RPMI 1640 medium, trypsin–EDTA, penicillin and streptomycin
were purchased from GIBCO (Invitrogen, Carlsbad, CA, USA). Pro-
pidium iodide (PI), acridine orange (AO), ethidium bromide (EB)
and Rhodamine 123 (Rho-123) were purchased from Sigma–Al-
drich Co. (St. Louis, MO, USA). Doxorubicin (Doxolem) was pur-
chased from Zodiac Produtos Farmacêuticos S/A, Brazil. All other
chemicals and reagents used were of analytical grade. a-Santonin
(compound 1) (97%) was procured from Sigma–Aldrich Co. (Mil-
waukee, WI, USA) and was utilized without further puriﬁcation.
The transformation of a-santonin (compound 1) into lactone (com-
pound 2), and its further transformation into (compound 3) and
(compound 4) were carried out as previously described (Arantes
et al., 2010) (Fig. 1).
2.2. Study of the mechanisms involved in the cytotoxic activity on HL-
60 cells
Since HL-60 cell line was the most sensitive cell line to a-santo-
nin derivatives (Arantes et al., 2010), it was selected to evaluate the
mechanism underlying to their cytotoxic effects after 24 h expo-
sure. The compounds dissolved in DMSO (0.1%) were added to cell
cultures of HL-60 cells (3  105 cells/mL) to obtain ﬁnal concentra-
tions of 1 and 2 lM. Doxorubicin (0.6 lM) was used as a positive
control (Dox). All ﬂow cytometry analyses were performed in a
Guava EasyCyte Mine using Guava Express Plus CytoSoft 4.1 soft-
ware (Guava Technologies Inc., Industrial Blvd., Hayward, CA, USA).
Five thousand events were evaluated per experiment and cell deb-
ris was omitted from the analysis.
2.2.1. Trypan blue exclusion test
Cell viability was determined by the trypan blue dye exclusion
test (Kepp et al., 2011). The cell samples were diluted in trypan
blue dye of an acid azo exclusion medium by preparing a 1:1Fig. 1. Structures of a-santonin (1) andilution of the cell suspension using a 0.4% trypan blue solution.
Non-viable cells were labeled in blue and are visible with bright-
ﬁeld optics and viable cells were unstained, since viable cells main-
tain the capacity to extrude this vital dye. The count was
performed under the microscope in four 1  1 mm squares of a
Neubauer chamber. Number of cells (104 cells/mL) was stated
and viable and non-viable cells were expressed as a percentage
of total cells.
2.2.2. Inhibition of DNA synthesis detected by immunocytochemistry
Cells were plated in 24-well tissue culture plates (2 mL/well)
and treated with the compounds. After 21 h exposure, 20 lL of 5-
bromo-20-deoxyuridine (BrdU, 10 mM) was added and incubated
for 3 h at 37 C. To determine the amount of BrdU incorporated
into DNA (Pera et al., 1977), cells were harvested, transferred to
cytospin slides, and allowed to dry for 2 h at room temperature
(25 C). Cells were labeled using direct peroxidase immunocyto-
chemistry by the chromogen diaminobenzidine (DAB) staining
those cells that incorporated Brd. Slides were counterstained with
hematoxylin and coverslipped. The determination of BrdU positiv-
ity was performed by light microscopy (Olympus, Tokyo, Japan).
Two hundred cells were counted per sample to determine the per-
centage of BrdU-positive cells (Costa et al., 2008).
2.2.3. Morphological analysis with ﬂuorescence microscopy
To determine whether the growth inhibition activity of com-
pounds 2–4 was related to the induction of apoptosis or necrosis,
morphological analysis of treated cells was investigated by ﬂuores-
cent microscopy using acridine orange/ethidium bromide (AO/EB)
staining. After 24 h incubation, cells were pelleted and each sample
was mixed with 1 L of aqueous AO/EB solution (100 g/mL of AO in
PBS; 100 g/mL EB in PBS) just prior to ﬂuorescence microscopy and
quantiﬁcation (Olympus, Tokyo, Japan). Three hundred cells were
counted per sample and scored as follows: viable cells, apoptotic
cells and necrotic cells (Cury-Boaventura et al., 2004; Tamatani
et al., 2012). The percentage of apoptotic and necrotic cells was
then calculated.
2.2.4. Cell cycle distribution and internucleosomal DNA fragmentation
analysis
Cell cycle distribution and DNA fragmentation analysis were
evaluated by the incorporation of propidium iodide (50 lg/mL).
Brieﬂy, 24 h-treated and untreated cells (3  105 cells/mL) were
incubated at 37 C for 30 min in the dark, in a lysis solution con-
taining 0.1% citrate, 0.1% Triton X-100 and 50 lg/mL propidium io-
dide and ﬂuorescence was measured afterwards.
2.2.5. Cell membrane integrity
Cell membrane integrity was evaluated by the exclusion of pro-
pidium iodide. Brieﬂy, 100 lL of treated and untreated cells were
incubated with propidium iodide (50 lg/mL). The cells were then
incubated for 5 min at 37 C. Fluorescence was measured and cell
morphology, granularity and membrane integrity were determined
(Darzynkiewicz et al., 1992).d its synthetic derivatives (2–4).
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PS externalization was analyzed by ﬂow cytometry (Annexin V)
according to Vermes and co-works (1995) using Guava Nexin As-
say Kit. Brieﬂy, cells (3  105 cells/mL) were washed twice with
cold PBS and then resuspended in 135 lL of PBS with 5 lL of 7-
aminoactinomycin D (7-AAD) and 10 lL of Annexin V-PE. Cells
were gently vortexed and incubated for 20 min at room tempera-
ture (22 ± 2 C) in the dark. Afterwards, cells were analyzed by ﬂow
cytometry (EasyCyte from Guava Technologies). Annexin V is a
phospholipid-binding protein that has a high afﬁnity for PS.
7-AAD, a cell impermeant dye, is used as an indicator of membrane
structural integrity. Fluorescence of Annexin V-PE was measured in
yellow ﬂuorescence-583 nm and 7-AAD in red ﬂuorescence-
680 nm. The percentage of early and late apoptotic cells and necro-
tic cells was then calculated.
2.2.7. Detection of caspase 3 and 7
Active catalytically caspases-3/7 were analyzed by ﬂow cytom-
etry using Guava EasyCyte Caspase Kit after 24 h of incubation.
HL-60 cells (3  105 cells/mL) were incubated with Fluorescent La-
beled Inhibitor of Caspases (FLICAs) and maintained for 1 h at 37 C
and 5% CO2. After incubation, 80 lL of washing buffer were added
and cells were centrifuged at 2000 rpm for 5 min. The resulting
pellet was resuspended in 200 lL of washing buffer and centri-
fuged again. Then, cells were resuspended in the working solution
(propidium iodide 1:200 in 1 washing buffer) and analyzed
immediately by ﬂow cytometry.
2.2.8. Measurement of mitochondrial transmembrane potential
(Dwm)
Mitochondrial transmembrane potential was determined by
rhodamine 123 dye retention using ﬂow cytometry. Rhodamine
123 is a cell-permeable, cationic, ﬂuorescent dye that is readily
sequestered by lively mitochondria without inducing cytotoxic ef-
fects. Cells (3  105 cells/mL) were washed with PBS, incubated
with rhodamine 123 at 37 C for 15 min in the dark. Cells were
incubated again in PBS at 37 C for 30 min in the dark, and ﬂuores-
cence was measured (Militão et al., 2006).
2.3. In vitro alkaline comet assay
Heparinized blood was collected from healthy, non-smoker do-
nors who had not taken any medication for at least 15 days prior to
sampling and with no history of recent exposure to potentially
genotoxic substances (i.e., pesticides, drugs, alcohol, tobacco or
ionizing radiation, such as X-rays). All studies were performed in
accordance with Brazilian (Law 196/96, National Council of Health)
and international (Declaration of Helsinki) guidelines.
Human peripheral blood mononuclear cells (PBMCs) were iso-
lated by the standard method of density-gradient centrifugation
over Histopaque-1077. Cells were washed and resuspended in
RPMI 1640 medium supplemented with 20% fetal bovine serum,
2 mM glutamine, 100 U/mL penicillin and 100 lg/mL streptomy-
cin, at 37 C under 5% CO2. Phytohemagglutinin (4%) was added
at the beginning of culture. After 24 h of culture, PBMC were trea-
ted with the test substances.
The alkaline comet assay was performed as described by Singh
et al. (1988) with minor modiﬁcations (Hartmann and Speit, 1997),
and following the recommendations of the International Workshop
on Genotoxicity Test Procedures (Tice et al., 2000). At the end of
the treatment, cells were washed with ice-cold PBS, detached with
100 lL trypsin (0.15%) and resuspended in complete RPMI med-
ium. Next, 20 lL of cell suspension (106 cells/mL) were mixed
with 100 lL of 0.75% low melting point agarose and immediately
spread onto a glass microscope slide precoated with a layer of 1%
normal melting point agarose. Agarose was allowed to set at 4 Cfor 5 min. The slides were incubated in ice-cold lysis solution
(2.5 M NaCl, 10 mM Tris, 100 mM EDTA, 1% Triton X-100 and 10%
DMSO, pH 10.0) at 4 C for a minimum of 1 h to remove cellular
proteins, leaving the DNA as ‘‘nucleoids’’. After the lysis procedure,
the slides were placed on a horizontal electrophoresis unit. The
unit was ﬁlled with fresh buffer (300 mM NaOH and 1 mM EDTA,
pH > 13.0) to cover the slides for 20 min at 4 C to allow DNA
unwinding and expression of alkali-labile sites. Electrophoresis
was carried out for 20 min at 25 V and 300 mA (0.86 V/cm). After
electrophoresis, the slides were neutralized (0.4 M Tris, pH 7.5),
stained with ethidium bromide (20 lg/mL) and analyzed using a
ﬂuorescence microscope. All the above steps were conducted un-
der yellow light or in the dark to prevent additional DNA damage.
Images of 100 randomly selected cells (50 cells from each of two
replicate slides) were analyzed for each concentration of test sub-
stance. Cells were scored visually and classiﬁed in 5 grades accord-
ing to the tail size (from undamaged-0 to maximally damaged-4),
and a damage index value was calculated for each sample of cells.
Damage index thus ranged from 0 (completely undamaged: 100
cells  0) to 400 (with maximum damage: 100 cells  4) (Collins,
2004). The frequency of tailed cells, a DNA damage frequency indi-
cator, was also calculated based on the number of cells with or
without tails.2.4. Statistical analysis
In order to determine differences among treatments, data were
compared by one-way analysis of variance (ANOVA) followed by
the Newman–Keuls test (p < 0.05) using the Graphpad program
(Intuitive Software for Science, San Diego, CA). All studies were car-
ried out in triplicate represented by independent biological
evaluations.3. Results
3.1. Antiproliferative effects of santonin derivatives
The indirect inhibitory growth effects of a-santonin derivatives
(2–4) on HL-60 cells were determined by MTT assay in a previous
study (Arantes et al., 2010, 2009). The derivatives showed high
activity, possessing IC50 values in the range of 1.1–2.3 lM on HL-
60 cells. Regarding to normal cells (PBMC), IC50 values ranged from
3.2 to 13.4 lM and were less pronounced than those found in can-
cer cells.
As shown in Fig. 2A, compounds 2, 3 and 4 caused reduction in
HL-60 cell number in the concentration of 2 lM after 24 h treat-
ment and evaluation by trypan blue exclusion test (46.7 ± 2.0,
43.0 ± 2.1 and 48.5 ± 3.3  104 cells/mL, respectively) when com-
pared to control cells (65 ± 5.5  104 cells/mL) (p < 0.05), while
no differences between the compounds were noticed (p > 0.05).
The positive control Dox also caused a signiﬁcant reduction on via-
ble cell population (42.2 ± 1.0  104 cells/mL, p < 0.05). Interest-
ingly, though all compounds has decreased cell number after
24 h exposure, none of them altered viability of the remaining
cells, since it was not noticed statistically signiﬁcant differences
in viable and non-viable cells in comparison to control (Fig. 2B).
The cytotoxicity is not related to the membrane lysis of leukemia
cells, since compounds 3 and 4 did not led to membrane disruption
or increased ﬂuorescence after ethidium bromide incorporation.
The exception was the compound 2 (2 lM), which induced a slight
but signiﬁcant decreasing in cells with intact membranes
(93.0 ± 1.6%, p < 0.05) (Fig. 2C). Since sesquiterpene lactones are
known inhibitors of enzymes and cellular processes, we investi-
gated whether the inhibition of cell proliferation is related to
DNA synthesis inhibition using the BrdU assay. This method
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Fig. 2. Effects of the a-Santonin derivatives 2, 3 and 4 (1 and 2 lM) on HL-60
leukemia cell number (A), remaining cell viability (B) and determined by trypan
blue exclusion test and membrane integrity analyzed using ﬂow cytometry after
24 h exposure (C). Negative control was incubated with the vehicle used to dilute
the molecules (DMSO 0.1%). Doxorubicin (0.6 lM) was used as positive control
(Dox). Results are expressed as mean ± standard error of measurement (SEM) from
three independent experiments. p < 0.05 compared by one-way analysis of
variance (ANOVA) followed by the Newman–Keuls test.
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ration, presenting the compound 4 the highest potential to dimin-
ish BrdU-positive cells in both dose tested (1 lM and 2 lM,
28.5 ± 2.2% and 28 ± 1.9%, respectively) in comparison to negative
control (51.4 ± 3.15%).3.2. Santonin derivatives induced cell cycle arrest and DNA
fragmentation
To deﬁne the mechanism responsible for the action of santonin
derivatives involved on HL-60 cell death, cell-cycle distribution
was assessed after 24 h and 48 h of treatment (Fig. 3A and B). A sig-
niﬁcant inhibition on HL-60 cell-cycle progression was observed
within 24 h, where Dox (37 ± 3.4%), compound 3 (7.6 ± 0.5% and
9.0 ± 0.9%) and 4 (9.0 ± 0.9% and 8.6 ± 9.6%) (1 and 2 lM, respec-
tively) caused an increasing of cells in G2/M phase when compared
to untreated cells (3.4 ± 0.5%). On the other hand, 48 h exposure
provoked G2/M reduction [(2.6 ± 0.7% and 1.5 ± 1.0%), (1.7 ± 0.3%
and 1.5 ±.0.5%) and (0.6 ± 0.2% and 1.0 ± 0.8%), for compounds 2,
3 and 4, respectively] when compared to negative control
(5 ± 0.8%) (Fig. 3C, p < 0.05), ﬁndings indicating time and concen-
tration dependent activity of the molecules. Interestingly, only
compound 2 at highest concentration was able to increase sub-
G0/G1 DNA content after 24 h (34 ± 4.8%, indicated in pink part)
in comparison with control (13 ± 1.3%) (Fig. 3D). However, after48 h exposure, a-santonin derivatives 3 and 4 also caused increas-
ing on DNA fragmentation [(45.3 ± 1.2% and 91.0 ± 2.0%) and
(64.4 ± 1.8% and 83.8 ± 4.8%), respectively] in both concentrations
tested (1 lM a 2 lM, p < 0.05), though the compound 2 has in-
creased DNA fragmentation only at 2 lM (75 ± 5.6%, p < 0.05,
Fig. 3D).
3.3. Santonin derivatives induces cell death by apoptosis
To corroborate the suggestion the mechanism of action, we ex-
plored some hallmarks of apoptosis during a 24 h HL-60 cell expo-
sure to the a-santonin derivatives (2, 3 and 4).
3.3.1. Acridine orange/ethidium bromide staining
For this purpose, HL-60 cells treated with the lactones 2, 3, and
4 were stained with AO/EB in order to discriminate cells undergo-
ing necrosis or apoptosis. The compounds 2, 3 and 4 were able to
reduce the number of viable cells at higher concentrations [2 lM
(77.3 ± 1.5%, 70.7 ± 0.1% and 70.1 ± 2.1%)] and to expand the apop-
tosis level (20.5 ± 1.6%, 26.6 ± 0.4% and 26.4 ± 1.5%), respectively
(p < 0.05). On the other hand, compound 4 was the single concen-
tration capable to decrease the number of viable cells at 1 lM
(84.1 ± 1.5%) when compared to negative control (92.5 ± 0.5%)
(p < 0.05, respectively). At lowest concentrations, compounds 2, 3
and 4 also induced apoptosis (14.0 ± 1.1% and 11.8 ± 0.6% and
13.6 ± 1.6%, respectively) (Fig. 4, p < 0.05), though in lower levels.
The positive control (Dox, 0.6 lM) reduced viable cells
(60.0 ± 7.3%) and increased apoptosis (36.2 ± 4.8%).
When examined under light microscopy, control cells exhibited
a typical non-adherent and round morphology, while derivatives-
treated cells displayed chromatin condensation, nuclear fragmen-
tation and shrinking in all concentrations tested (Fig. 4). Dox also
induced cell reduction and nuclear disintegration.
3.3.2. Santonin derivatives induces phosphatidylserine externalization
Phosphatidylserine externalization was determined using An-
nexin V test as a marker of apoptosis. Annexin V, a 35 kDa Ca2+
phospholipid-binding protein, binds to the phosphatidylserine on
the outer layer of the plasma membrane with a high afﬁnity due
to loss of polarity whereas propridium iodide (PI) bind to cells that
lost membrane integrity (Krysko et al., 2008). After 24 h exposure,
compounds 2, 3 and 4 at 2 lM were able to reduce cell viability
(90.2 ± 1.5%, 89.5 ± 1.6% and 86.7 ± 2.7%), to induce early
(7.5 ± 0.8%, 7.6 ± 1.0% and 8.7 ± 0.7%) and late apoptosis
(0.8 ± 0.1%, 0.6 ± 0.1% and 0.7 0.2%) and necrosis (1.6 ± 0.3%,
1.4 ± 0.1% and 1.6 ± 0.4%) on leukemia cells in comparison with
control (92.5 ± 0.6%, 5.9 ± 1.0%, 0.2 ± 0.1% and 0.4 ± 0.1%, respec-
tively) (Fig. 5A, p < 0.05). Meanwhile, Dox-treated tumor cells also
revelaed cell viability decreasing (50.5 ± 0.2%), high levels of early
apoptosis (47.5 ± 0.3%) and necrosis (1.6 ± 0.1%) following 24 h of
treatment (p < 0.05).
3.3.3. Caspase cell activation
The main characteristic of cell undergoing apoptosis is the acti-
vation of caspases. The caspases can be categorized into initiator
(8, 9 and 10) and executing caspases (3, 6 and 7) (Hanahan and
Weinberg, 2011). At highest concentration, the compounds 2, 3
and 4 reduced cell viability (83.2 ± 5.2%, 83.4 ± 6.6% and
76.3 ± 8.5%) and increased the number of early (7.3 ± 2%,
5.8 ± 2.5% and 9.1 ± 4.1%) and late apoptosis cells (4.5 ± 0.8%,
5.0 ± 0.7% and 4.8 ± 0.5%, respectively) in comparison with nega-
tive control (94.3 ± 1.5%, viable cells; 1.7 ± 0.9%, early apoptosis
and 1.5 ± 0.2%, late apoptosis) (p < 0.05) (Fig. 5B). Similarly, Dox
also caused a signiﬁcant cell viability decreasing (16.1 ± 0.1%)
and early apoptosis rising (83.2 ± 0.1%).
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Fig. 3. Effects of the a-santonin derivatives 2, 3 and 4 (1 and 2 lM) on HL-60 cell cycle evaluated by ﬂow cytometry using propidium iodide, Triton X-100 and citrate. General
view of the cell cycle (A and B), percentage of cell number in G2/M phase (C) and DNA fragmentation (D) after 24 h and 48 h of treatment. Negative control (C) was treated
with the vehicle used for diluting the tested substance. Dox (0.6 lM) was used as positive control (Dox). Results are expressed as mean ± standard error of measurement
(SEM) from three independent experiments. p < 0.05 compared by one-way analysis of variance (ANOVA) followed by the Newman–Keuls test.
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Another early marker of the apoptotic process is the depletion
of mitochondria membrane potential. In this work, none of the
compounds evaluated in 24 h of treatment signiﬁcantly alter the
mitochondrial membrane potential (p > 0.05), suggesting that only
the extrinsic pathway was activated within 24 h. However, in 48 h
exposure, compound 4 (2 lM) caused depolarization of mitochon-
drial membrane potential (37.3 ± 4.6%, Fig. 5C) when compared to
negative control (4.7 ± 0.6%, p < 0.05). Dox, positive control, causeintense membrane depolarization after 24 h (44.0 ± 2.3%) and
48 h (46.9 ± 5.4%) of incubation.3.4. Comet assay
The DNA damage induced by the a-santonin derivatives was
evaluated in humanmononuclear cells. DNA damages were not de-
tected with the concentrations tested (p > 0.05, data not shown).
Fig. 4. Cell death pattern determined by acridine orange/ethidium bromide (AO/EB) after 24 h exposure. Control (C) was treated with the vehicle used for diluting the tested
substance. Doxorubicin (0.6 lM) was used as positive control (Dox). Results are expressed as mean ± standard error of measurement (SEM) from three independent
experiments. p < 0.05 compared by one-way analysis of variance (ANOVA) followed by the Newman–Keuls test.
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Sesquiterpene lactones (SLs) are plant-derived compounds of-
ten used in traditional medicine against several human diseases
such as inﬂammation and cancer (Ghantous et al., 2010). Previous
researches showed no cytotoxic activity of the a-santonin mole-
cule, even at high concentrations (100 lM) (Kim et al., 2002;
Konaklieva and Plotkin, 2005). Then, we designed three cytotoxic
sesquiterpene lactones based on a-santonin (Arantes et al., 2009;
2010) with activity on different cancer cell lines and low toxicity
on PBMC. In this work, we propose the mechanism responsible
for this cytotoxicity using the HL-60 cell line as experimental
model and the compounds tested (1 and 2 lM) after 24 h of
treatment.
Initially, we showed that the antiproliferative potential of the a-
santonin derivatives is not related to direct membrane damages,
since the trypan and propidium iodide exclusion techniques did re-
veal membrane permeability of remaining cells. In fact, it is possi-
ble that apoptosis or other process might have already
compromised cell proliferation, but membrane integrity is still
maintained (Kepp et al., 2011). We previously reported that these
derivatives did not produce cell membrane disruption of mouse
erythrocytes (Arantes et al., 2010).
Some studies have been pointed that SLs inhibit tumor growth
by selective alkylation of growth-regulatory biological macromole-
cules, such as DNA and key enzymes, which control cell division,
thereby inhibiting a variety of cellular functions, which leads cells
into apoptotic death (Fernandes et al., 2008; Rozenblat et al.,
2008). Herein, all molecules reduced BrdU incorporation by HL-
60 treated cells, suggesting inhibition of DNA synthesis. Other
SLs caused inhibition of DNA synthesis by BrdU test such asenhydin, uvedalin and sonchifolin (Siriwan et al., 2011). The apop-
totic effect of these SLs is associated with caspase 3/7 activation.
All compounds (2, 3 and 4) increased cell death with morpho-
logical characteristics of apoptosis and reduced the number viable
cells at 2 lM, whose concentration decreased plasma membrane
integrity as seen by trypan blue test. Furthermore, AO/BE staining
analysis after 24 h of incubation revealed treated cells displaying
typical apoptotic and necrotic features, including reduction in cell
volume, intense karyorrhexis, pyknotic nuclei typical of necrotic
processes and signs of plasma membrane destabilization, which
indicates quick activation of apoptosis pathways that culminate
in secondary necrosis activation (de Bruin and Medema, 2008).
Dose-dependent regulation of cellular processes is one of the most
important characteristics of signaling molecules naturally occur-
ring in cells. Therefore, depending on the concentration used, many
different processes may be inﬂuenced and/or altered. Indeed, trea-
ted cells displayed apoptotic features at concentrations as low as
1 lMwith an increase of necrotic cells at 2 lM, probably as a result
of a later apoptosis stage.
To elucidate the probable mechanism by the antiproliferative
effects of a-santonin derivatives (B–D), we ﬁrst examined whether
inhibition of cell viability by the SLs was associated with changes
in cell cycle progression. Compounds 3 and 4 produced cell cycle
arrest at G2/M transition. The cell cycle arrest reﬂects a require-
ment to repair cell damages; if not repaired, apoptotic mechanisms
are often activated (Rozenblat et al., 2008). Other SLs are known to
arrest cell cycle. Thus, the molecules 6-O-angeloylenolin and
dehydrocostuslactone induced cell-cycle arrest and apoptosis in
human nasopharyngeal and ovarian cancer cells, respectively (Su
et al., 2011). Tomentosin (36 and 54 lM) and Inuviscolide (36
and 72 lM) caused cell cycle arrest at G2/M, phosphatidylserine
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Fig. 5. Flow cytometry analysis of the death pattern in HL-60 cells treated with a-santonin derivatives 2, 3 and 4 (1 and 2 lM) performed with Annexin V-PE and 7-amino-
actinomycin-D (phosphatidylserine externalization) (A) and FLICA™ solution (activation of caspases-3 and -7) after 24 h (B) and rhodamine 123 (mitochondrial
transmembrane potential) at 24 h and 48 h exposure (C). Negative control (C) was treated with the vehicle used for diluting the tested substance. Doxorubicin (0.6 lM) was
used as positive control (Dox). Results are expressed as mean ± standard error of measurement (SEM) from three independent experiments. p < 0.05 compared by one-way
analysis of variance (ANOVA) followed by the Newman–Keuls test.
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G0/G1 subpopulation represented DNA fragmentation on ﬂow
cytometry cell cycle assay (Krysko et al., 2008). In this event, only
the compound 2 at highest concentration was able to cause DNA
fragmentation following 24 h exposure. On the other hand, after
48 h all compounds induced DNA fragmentation. Internucleosomal
DNA fragmentation is a nuclear feature of apoptosis and double-
stranded DNA disintegration is attributed to caspases (Huerta
et al., 2007), cysteine aspartate-speciﬁc proteases synthesized as
zymogens that cleave different proteins (Krysko et al., 2008). These
enzymes are involved in two different apoptotic pathways: the
intrinsic and extrinsic pathways, each possessing your speciﬁc ini-
tiator enzymes (caspase-9 and -8, respectively). Both pathways can
activate executor caspases (caspase-3, -6 and -7), being caspase-3
the major effector caspase that predominantly triggers laminin
and nuclear mitotic apparatus collapse (Hanahan and Weinberg,
2000, 2011; Widlak and Garrard, 2009). While necrotic cells pres-
ent random DNA fragmentation, the caspases produce a pattern
damaged DNA with intervals of 180–200 base pairs (Krysko
et al., 2008). Herein, all molecules assessed induced caspases acti-
vation, with intensiﬁcation in early and late apoptotic processes.
The phosphatidylserine externalization induced at 2 lM is an
additional ﬁnding that corroborates activation of pathwayssuggestive of apoptosis. Loss of membrane polarity, caused by
translocation of phosphatidylserine from the inner to outer plasma
membrane, thereby exposing phosphatidylserine for external envi-
ronment, stimulates recognition and engulfment of dying cells by
macrophages and other antigen presenting cells (Kroemer et al.,
1997).
In order to improve comprehension about cell signaling, it was
performed a mitochondrial depolarization analyses. Apoptosis
stimulation by the mitochondrial via starts with a pore formation
in the external membrane mitochondrial and release of cyto-
chrome c, with permeability changes and mitochondrial mem-
brane potential collapse. This failure can be measured by cationic
lipophilic ﬂuorochromes, such as rhodamine 123 (de Thonel and
Eriksson, 2005). Within 24 h of treatment, a-santonin derivatives
did not induce modiﬁcations in mitochondrial potential. However,
following 48 h, the compound 4 induced mitochondrial depolariza-
tion, an indicative of apoptosis intrinsic pathway activation com-
monly caused in reaction to DNA damage, absence of survivor
factors and several types of cellular stress. Whereas caspase-8
was activated, it is likely that it had been occurred convergence
into apoptosis intrinsic pathway downstream from the extrinsic
route. Costunolide, a sesquiterpene lactone structure close to a-
santonin, induces G2/M cell cycle arrest and cause apoptosis on
several cell tumor lines through extrinsic pathway before intrinsic
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tic protein belonging to BCL-2 family that also activates mitochon-
drial pathways (Liu et al., 2011). This indirectly mitochondrial
involvement could explain a longer extensive interval required
(48 h) by a-santonin derivatives 2 and 4 to instigate cell damage,
which culminates with mitochondrial depolarization and DNA
destabilization (de Thonel and Eriksson, 2005; Liu et al., 2011; Choi
et al., 2012; Guzman and Jordan, 2005).
Sesquiterpene lactones have a privileged selectivity for tumor
cells (Ghantous et al., 2010). Previously, compounds 2, 3 and 4
were tested against normal cells (PBMC) and showed low toxicity
(Arantes et al., 2010). Here, the same ones were tested in alkaline
comet assay to analyze their ability to cause DNA alkylation on
PBMC. None of compounds were able to DNA disruptions in both
concentrations tested (data not shown). Similarly, it was displayed
that Parthenolide, another sesquiterpene lactone, selectively kill
primitive leukemia cells without affecting normal stem and pro-
genitor hematopoietic cells (Guzman and Jordan, 2005).
5. Conclusions
We propose the extrinsic pathway of apoptosis as the central
via involved in cell death induced by these a-santonin derivatives.
The compounds showed low toxicity effects on normal and higher
cytotoxic on tumor cells, a very desired advantage in new lead
anticancer chemicals to overwhelmed adverse effects due to ther-
apeutic narrow window, pharmacological multiple resistance and
morphological and physiological similarities between transformed
and normal cells.
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